Press release
Artificial Intelligence (AI) in Drug Discovery Market Size Hits USD 11,874.24 Million by 2032, Surging with 37.5% CAGR
The major players in the artificial intelligence ( ai) in drug discovery market include IBM Corporation, Microsoft, Google, Nvidia Corporation, Atomwise Inc., Deep Genomics Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica, Bioage.
Get more information on "Global Artificial Intelligence (AI) in Drug Discovery Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/artificial-intelligence-ai-in-drug-discovery-market/download-sample
The global AI in drug discovery market is poised for significant expansion as pharmaceutical companies and research institutions continue to leverage advanced AI technologies to enhance drug development processes. With ongoing advancements in AI and increasing investments in research, the market is expected to grow substantially, offering opportunities for innovation and improved therapeutic outcomes.
Artificial Intelligence (AI) has increasingly transformed the pharmaceutical industry, revolutionizing drug discovery and development processes. By leveraging advanced computational techniques, machine learning, and data analytics, AI is streamlining the identification of new drug candidates, optimizing clinical trials, and accelerating the overall drug development timeline. This report provides a comprehensive analysis of the global AI in drug discovery market, focusing on various segments including drug type, offering, application, end-user, and regional insights.
The AI in drug discovery market has witnessed substantial growth, driven by the increasing demand for faster and more efficient drug development processes. The integration of AI technologies helps in predicting drug interactions, optimizing clinical trial designs, and identifying potential drug candidates with higher accuracy. As the pharmaceutical industry continues to embrace digital transformation, the market for AI in drug discovery is expected to expand significantly over the forecast period from 2023 to 2032.
Market Segmentation
1 By Drug Type
Large Molecule: AI technologies are increasingly applied in the development of large molecules, such as biologics and monoclonal antibodies. These complex drugs often require sophisticated predictive models for their design and optimization.
Small Molecule: AI is extensively used in the discovery of small molecules, including traditional drugs and new chemical entities. AI algorithms assist in identifying novel compounds and optimizing their efficacy and safety profiles.
2 By Offering
Software: AI software solutions for drug discovery include predictive modeling tools, data analytics platforms, and virtual screening applications. These tools enable researchers to analyze large datasets, identify drug candidates, and optimize drug designs.
Services: AI service providers offer consulting, data management, and implementation services. These services help pharmaceutical companies integrate AI technologies into their drug discovery processes, including customized solutions for specific research needs.
Browse Global Artificial Intelligence (AI) in Drug Discovery Market Research Report with detailed TOC at https://www.valuemarketresearch.com/report/artificial-intelligence-ai-in-drug-discovery-market
3 By Application
Immuno-oncology: AI is used to identify potential immuno-oncology targets, develop personalized cancer therapies, and analyze patient data to enhance treatment efficacy.
Neurodegenerative Diseases: AI applications in neurodegenerative diseases focus on identifying biomarkers, predicting disease progression, and developing targeted therapies for conditions such as Alzheimer's and Parkinson's diseases.
Cardiovascular Diseases: AI tools aid in the discovery of novel drug targets and therapies for cardiovascular diseases by analyzing patient data and identifying patterns related to heart disease.
Metabolic Diseases: AI helps in understanding the underlying mechanisms of metabolic diseases such as diabetes and obesity, facilitating the development of new therapeutic approaches.
Other: This category includes various other therapeutic areas where AI applications are emerging, such as infectious diseases, rare diseases, and autoimmune disorders.
4 By End User
Pharmaceutical & Biotechnology Companies: These entities are the primary adopters of AI technologies, leveraging them to streamline drug discovery processes, reduce costs, and enhance research outcomes.
Contract Research Organizations (CROs): CROs use AI to provide outsourced drug discovery services, offering expertise in data analysis, predictive modeling, and clinical trial management.
Research Centers and Academic Institutes: These organizations utilize AI for research purposes, including the development of novel methodologies and the exploration of new drug targets.
Government Institutes: Government bodies and public research institutions employ AI to support drug discovery initiatives, particularly in the context of public health and disease management.
5 By Region
North America: The North American market dominates the global AI in drug discovery sector, driven by the presence of leading pharmaceutical companies, advanced technological infrastructure, and significant R&D investments.
Europe: Europe is experiencing growth in AI-driven drug discovery, supported by strong pharmaceutical and biotech industries and collaborative research initiatives.
Asia-Pacific: The Asia-Pacific region is emerging as a key market for AI in drug discovery, with increasing investments in healthcare technology and a growing number of research collaborations.
Latin America: Latin America is witnessing gradual adoption of AI technologies in drug discovery, with increasing support from government initiatives and research institutions.
Middle East & Africa: The market in the Middle East and Africa is expanding, driven by improving healthcare infrastructure and increasing focus on research and development.
Purchase Complete Global Artificial Intelligence (AI) in Drug Discovery Market Research Report at https://www.valuemarketresearch.com/contact/artificial-intelligence-ai-in-drug-discovery-market/buy-now
Market Trends:
Increasing Investment in AI Research: Significant investments are being made in AI research and development, focusing on enhancing drug discovery capabilities and exploring new applications.
Collaborations and Partnerships: Collaborations between pharmaceutical companies, AI technology providers, and research institutions are fostering innovation and accelerating the adoption of AI in drug discovery.
Personalized Medicine: The shift towards personalized medicine is driving the demand for AI technologies that can analyze individual patient data and develop targeted therapies.
Regulatory Support: Growing support from regulatory agencies for the use of AI in drug discovery is facilitating market growth and encouraging the development of AI-driven solutions.
See More Related Reports:
Global Artificial Intelligence In Healthcare Market Report
https://www.valuemarketresearch.com/report/artificial-intelligence-in-healthcare-market
Global Drug Discovery Informatics Market Report
https://www.valuemarketresearch.com/report/drug-discovery-informatics-market
Contact:
Value Market Research
UG-203, Gera Imperium Rise,
Wipro Circle Metro Station, Hinjawadi, Pune - 411057
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: sales@valuemarketresearch.com
Website: https://www.valuemarketresearch.com
About Us:
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.
We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Intelligence (AI) in Drug Discovery Market Size Hits USD 11,874.24 Million by 2032, Surging with 37.5% CAGR here
News-ID: 3642843 • Views: …
More Releases from Value Market Research
Organic Baby Food Market Size Set to Reach $10.37 Billion by 2032
The global demand for the organic baby food market size is projected to surge significantly, with expectations of reaching a market size of approximately USD 10.37 billion by 2032, up from USD 4.73 billion in 2023. This growth represents a robust compound annual growth rate (CAGR) of 9.12% during the study period from 2024 to 2032. Factors driving this demand include increasing health consciousness among parents, a rising preference for…
Capsule Hotel Market Size Expected to Reach USD 5.38 Billion by 2032
The global Capsule Hotel Market Size is projected to experience significant growth, with an anticipated market size of approximately USD 5,384.51 million by 2032, up from USD 2,170.92 million in 2023. This growth represents a robust compound annual growth rate (CAGR) of 10.62% over the study period from 2024 to 2032. This surge in demand can be attributed to the increasing popularity of budget-friendly and space-efficient accommodation options among travelers,…
Terpenes Market Size Hits USD 518.84 Million in 2023, Projected to Grow at 5.47% …
The global terpenes market size was valued at USD 518.84 million in 2023 and is poised for significant growth over the next decade. Driven by increasing demand across various industries such as pharmaceuticals, cosmetics, and food and beverages, the market is projected to expand at a compound annual growth rate (CAGR) of 5.47% between 2024 and 2032. In terms of volume, the global terpenes market accounted for 108,036.67 tons in…
Optical Coating Market Size Hits USD 50.81 Billion by 2032, Driven by 10.2% CAGR
The global demand for the optical coating market size is projected to experience significant growth, with the market size expected to reach nearly USD 50.81 billion by 2032, up from USD 21.2 billion in 2023. This represents a compound annual growth rate (CAGR) of 10.2% over the forecast period from 2024 to 2032. Optical coatings, which enhance the transmission, reflection, and absorption properties of optical components, are becoming increasingly important…
More Releases for Artificial
Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences.
As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds…
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from…
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc.
The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to…
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes…
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction
Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs.
Artificial organs are surgically implanted or are extra…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
